Abstract
Platelet function tests are mainly used in the diagnostic work-up of platelet disorders. During the last decade, the additional use of platelet function tests to evaluate the effect of antiplatelet therapy has also emerged in an attempt to identify patients with an increased risk of arterial thrombosis. Furthermore, platelet function tests are increasingly used to measure residual effect of antiplatelet therapy prior to surgery with the aim of reducing the risk of bleeding. To a limited extend, platelet function tests are also used to evaluate hyperaggregability as a potential marker of a prothrombotic state outside the setting of antiplatelet therapy. This multifaceted use of platelet function tests and the development of simpler point-of-care tests with narrower application have increased the use of platelet function testing and also facilitated the use of platelet function tests outside the highly specialized laboratories. The present chapter describes the preanalytical variables, which should be taken into account when planning platelet function testing. Also, the most widely used platelet function tests are introduced, and their clinical utility and their relative advantages and disadvantages are discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Hvas AM (2016) Platelet function in thrombosis and hemostasis. Semin Thromb Hemost 42:183–184
Hoffman M, Monroe DM III (2001) A cell-based model of hemostasis. Thromb Haemost 85:958–965
Gremmel T, Frelinger AL III, Michelson AD (2016) Platelet physiology. Semin Thromb Hemost 42:191–204
George JN (2000) Platelets. Lancet 355:1531–1539
Kuwahara M, Sugimoto M, Tsuji S et al (2002) Platelet shape changes and adhesion under high shear flow. Arterioscler Thromb Vasc Biol 22:329–334
Gresele P, Bury L, Falcinelli E (2016) Inherited platelet function disorders: algorithms for phenotypic and genetic investigation. Semin Thromb Hemost 42:292–305
Lordkipanidze M (2016) Platelet function tests. Semin Thromb Hemost 42:258–267
Gross L, Aradi D, Sibbing D (2016) Platelet function testing in patients on antiplatelet medications. Semin Thromb Hemost 42:306–320
Sokol J, Skerenova M, Jedinakova Z et al (2017) Progress in the understanding of sticky platelet syndrome. Semin Thromb Hemost 43(1):8–13
Davis RB, Boyd DG, McKinney ME et al (1990) Effects of exercise and exercise conditioning on blood platelet function. Med Sci Sports Exerc 22:49–53
Naesh O, Hindberg I, Trap-Jensen J et al (1990) Post-exercise platelet activation—aggregation and release in relation to dynamic exercise. Clin Physiol 10:221–230
Natella F, Nardini M, Belelli F et al (2008) Effect of coffee drinking on platelets: inhibition of aggregation and phenols incorporation. Br J Nutr 100:1276–1282
Rival J, Riddle JM, Stein PD (1987) Effects of chronic smoking on platelet function. Thromb Res 45:75–85
Dalby MC, Davidson SJ, Burman JF et al (2000) Diurnal variation in platelet aggregation with the PFA-100 platelet function analyser. Platelets 11:320–324
Ahuja KD, Adams MJ, Robertson IK et al (2009) Acute effect of a high-carbohydrate low-fat meal on platelet aggregation. Platelets 20:606–609
McEwen BJ (2014) The influence of diet and nutrients on platelet function. Semin Thromb Hemost 40:214–226
McEwen BJ (2015) The influence of herbal medicine on platelet function and coagulation: a narrative review. Semin Thromb Hemost 41:300–314
Blomback M, Konkle BA, Manco-Johnson MJ et al (2007) Preanalytical conditions that affect coagulation testing, including hormonal status and therapy. J Thromb Haemost 5:855–858
Scharf RE (2012) Drugs that affect platelet function. Semin Thromb Hemost 38:865–883
Christie DJ, Avari T, Carrington LR et al (2008) Platelet function testing by aggregometry; Approved guideline. CSLI document H58-A. Clinical and Laboratory Standards (CSLI), Wayne, PA
Adcock DM, Hoefner DM, Kottke-Marchant K et al (2008) Collection, transport, and processing of blood specimens for testing plasma-based coagulation assays and molecular hemostasis assays; Approved guideline, 5th edn. CSLI document H21-A5-A. Clinical and Laboratory Standards Institute (CSLI), Wayne, PA
Harrison P, Mackie I, Mumford A et al (2011) Guidelines for the laboratory investigation of heritable disorders of platelet function. Br J Haematol 155:30–44
Toth O, Calatzis A, Penz S et al (2006) Multiple electrode aggregometry: a new device to measure platelet aggregation in whole blood. Thromb Haemost 96:781–788
Pignatelli P, Pulcinelli FM, Ciatti F et al (1995) Acid citrate dextrose (ACD) formula A as a new anticoagulant in the measurement of in vitro platelet aggregation. J Clin Lab Anal 9:138–140
Ginsberg MH, Lightsey A, Kunicki TJ et al (1986) Divalent cation regulation of the surface orientation of platelet membrane glycoprotein IIb. Correlation with fibrinogen binding function and definition of a novel variant of Glanzmann’s thrombasthenia. J Clin Invest 78:1103–1111
Storey RF, Wilcox RG, Heptinstall S (1998) Differential effects of glycoprotein IIb/IIIa antagonists on platelet microaggregate and macroaggregate formation and effect of anticoagulant on antagonist potency. Implications for assay methodology and comparison of different antagonists. Circulation 98:1616–1621
Dyszkiewicz-Korpanty A, Quinton R, Yassine J et al (2004) The effect of a pneumatic tube transport system on PFA-100 trade mark closure time and whole blood platelet aggregation. J Thromb Haemost 2:354–356
Milian M (1901) Contribution à l étude de la coagulation du sang. C R Soc Biol (Paris) 53:556
Duke WW (1910) The relation of blood platelets to hemorrhagic disease. Description of a method for determining the bleeding time and coagulation time and report of three cases of hemorrhagic disease relieved by transfusion. JAMA 55:1185–1192
Ivy AC, Nelson D, Bucher G (1941) The standardization of certain factors in the cutaneous “venostasis” bleeding time technique. J Lab Clin Med 26:1812–1822
Rodgers RP, Levin J (1990) A critical reappraisal of the bleeding time. Semin Thromb Hemost 16:1–20
Born GV (1962) Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194:927–929
O’Brien JR (1962) Platelet aggregation. Part II. Some results of a new method. J Clin Pathol 15:452–455
Cattaneo M (2009) Light transmission aggregometry and ATP release for the diagnostic assessment of platelet function. Semin Thromb Hemost 35:158–167
Grove EL, Storey RF, Wurtz M (2012) Platelet function testing in atherothrombotic disease. Curr Pharm Des 18:5379–5391
Cardinal DC, Flower RJ (1980) The electronic aggregometer: a novel device for assessing platelet behavior in blood. J Pharmacol Methods 3:135–158
Grove EL, Hossain R, Storey RF (2013) Platelet function testing and prediction of procedural bleeding risk. Thromb Haemost 109:817–824
Favaloro EJ, Lippi G, Franchini M (2010) Contemporary platelet function testing. Clin Chem Lab Med 48:579–598
Smith JW, Steinhubl SR, Lincoff AM et al (1999) Rapid platelet-function assay: an automated and quantitative cartridge-based method. Circulation 99(5):620
Kundu SK, Heilmann EJ, Sio R et al (1995) Description of an in vitro platelet function analyzer—PFA-100. Semin Thromb Hemost 21(Suppl 2):106–112
Favaloro EJ, Bonar R (2014) External quality assessment/proficiency testing and internal quality control for the PFA-100 and PFA-200: an update. Semin Thromb Hemost 40:239–253
Harrison P, Mumford A (2009) Screening tests of platelet function: update on their appropriate uses for diagnostic testing. Semin Thromb Hemost 35:150–157
Favaloro EJ (2008) Clinical utility of the PFA-100. Semin Thromb Hemost 34:709–733
Grove EL, Hvas AM, Johnsen HL et al (2010) A comparison of platelet function tests and thromboxane metabolites to evaluate aspirin response in healthy individuals and patients with coronary artery disease. Thromb Haemost 103:1245–1253
Hartert H (1948) Blutgerinnungsstudien mit der Thrombelastographie; einem neuen Untersuchungs verfahren. Klin Wochenschr 26:577–583
Chen A, Teruya J (2009) Global hemostasis testing thromboelastography: old technology, new applications. Clin Lab Med 29:391–407
Luddington RJ (2005) Thromboelastography/thromboelastometry. Clin Lab Haematol 27:81–90
Bolliger D, Seeberger MD, Tanaka KA et al (2012) Principles and practice of thromboelastography in clinical coagulation management and transfusion practice. Transfus Med Rev 26:1–13
Craft RM, Chavez JJ, Bresee SJ et al (2004) A novel modification of the Thrombelastograph assay, isolating platelet function, correlates with optical platelet aggregation. J Lab Clin Med 143:301–309
Scharbert G, Auer A, Kozek-Langenecker S (2009) Evaluation of the platelet mapping assay on rotational thromboelastometry ROTEM. Platelets 20:125–130
Gresele P, Harrison P, Bury L et al (2004) Diagnosis of suspected inherited platelet function disorders: results of a worldwide survey. J Thromb Haemost 12:1562–1569
Michelson AD, Barnard MR, Krueger LA et al (2000) Evaluation of platelet function by flow cytometry. Methods 21:259–270
Rubak P, Nissen PH, Kristensen SD et al (2016) Investigation of platelet function and platelet disorders using flow cytometry. Platelets 27:66–74
Ramstrom S, Sodergren AL, Tynngard N et al (2016) Platelet function determined by flow cytometry: new perspectives? Semin Thromb Hemost 42:268–281
Givan AL (2001) Principles of flow cytometry: an overview. Methods Cell Biol 63:19–50
Schwarz UR, Geiger J, Walter U et al (1999) Flow cytometry analysis of intracellular VASP phosphorylation for the assessment of activating and inhibitory signal transduction pathways in human platelets—definition and detection of ticlopidine/clopidogrel effects. Thromb Haemost 82:1145–1152
Mallouk N, Labruyere C, Reny JL et al (2012) Prevalence of poor biological response to clopidogrel: a systematic review. Thromb Haemost 107:494–506
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this protocol
Cite this protocol
Hvas, AM., Grove, E.L. (2017). Platelet Function Tests: Preanalytical Variables, Clinical Utility, Advantages, and Disadvantages. In: Favaloro, E., Lippi, G. (eds) Hemostasis and Thrombosis. Methods in Molecular Biology, vol 1646. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7196-1_24
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7196-1_24
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7194-7
Online ISBN: 978-1-4939-7196-1
eBook Packages: Springer Protocols